PCSK9 and Hypertension: Effective approaches include lipid-lowering medications (e.g., statins, ezetimibe, Proprotein convertase subtilisin/kexin type 9 [PCSK9]-inhibitors), antiplatelet drugs (with a risk-to-benefit balance more favorable in secondary prevention), and proper management of hypertension, diabetes, and other metabolic disturbances [15,16,17,18,19,20,21,22].